Full Text View
Tabular View
Study Results
Related Studies
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin (HMH)
This study has been terminated.
( Low enrollment )
Study NCT01136746   Information provided by Eli Lilly and Company

First Received on June 2, 2010.   Last Updated on November 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperglycemia
More general conditions related to this trial
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Human regular insulin
Insulin lispro
Insulin glargine
Additional drug interventions recognized in this trial
Glargine
Insulin
Insulin, Long-Acting
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services